Mostrar el registro sencillo del ítem

dc.contributor.author
Santucci, Luca  
dc.contributor.author
Fiorucci, Stefano  
dc.contributor.author
Rubinstein, Natalia  
dc.contributor.author
Mencarelli, Andrea  
dc.contributor.author
Pallazzeti, Barbara  
dc.contributor.author
Federici, Barbara  
dc.contributor.author
Rabinovich, Gabriel Adrián  
dc.contributor.author
Morelli, Antonio  
dc.date.available
2018-02-11T22:32:51Z  
dc.date.issued
2003-05  
dc.identifier.citation
Santucci, Luca; Fiorucci, Stefano; Rubinstein, Natalia; Mencarelli, Andrea; Pallazzeti, Barbara; et al.; Galectin-1 suppresses experimental colitis in mice; American Gastroenterological Association; Gastroenterology; 124; 5; 5-2003; 1381-1394  
dc.identifier.issn
0016-5085  
dc.identifier.uri
http://hdl.handle.net/11336/36410  
dc.description.abstract
Uncontrolled T-cell activation plays a critical role in the pathogenesis of inflammatory bowel diseases. Therefore, pharmacologic strategies directed to restore the normal responsiveness of the immune system by deleting inappropriately activated T cells could be efficacious in the treatment of these pathologic conditions. Galectin-1 is an endogenous lectin expressed in lymphoid organs that plays a role in the maintenance of central and peripheral tolerance. The aim of the present study was to evaluate the therapeutic effects of galectin-1 on T-helper cell type 1-mediated experimental colitis induced by intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS) in mice.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
American Gastroenterological Association  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Autoimmune Colitis  
dc.subject
Galectin-1  
dc.subject
Tumor Necrosis Factor Alpha  
dc.subject
Human Recombinant Galectin  
dc.subject
Irritable Bowel Disease  
dc.subject.classification
Otras Ciencias Médicas  
dc.subject.classification
Otras Ciencias Médicas  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Otras Ciencias Médicas  
dc.subject.classification
Otras Ciencias Médicas  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Galectin-1 suppresses experimental colitis in mice  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-12-28T17:49:38Z  
dc.journal.volume
124  
dc.journal.number
5  
dc.journal.pagination
1381-1394  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Bethesda  
dc.description.fil
Fil: Santucci, Luca. Università di Perugia; Italia  
dc.description.fil
Fil: Fiorucci, Stefano. Università di Perugia; Italia  
dc.description.fil
Fil: Rubinstein, Natalia. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Mencarelli, Andrea. Università di Perugia; Italia  
dc.description.fil
Fil: Pallazzeti, Barbara. Università di Perugia; Italia  
dc.description.fil
Fil: Federici, Barbara. Università di Perugia; Italia  
dc.description.fil
Fil: Rabinovich, Gabriel Adrián. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina  
dc.description.fil
Fil: Morelli, Antonio. Università di Perugia; Italia  
dc.journal.title
Gastroenterology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0016508503002671  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/S0016-5085(03)00267-1  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/pmid/12730878